Large Study Finds No Survival Benefit Associated With Removal Of Ovaries
ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer
Study Links Obesity To Higher Risk of Ovarian Cancer
Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
Early HER2 Positive Patients At Higher Risk of Recurrence
Tykerb Plus Letrozole Delayed Metastatic Breast Cancer
Estrogen Can Benefit Women With Metastatic Breast Cancer
Alternating Mammography, MRI Tested For High-Risk Women
Degarelix Approved For Advanced Prostate Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG
